How otherwise dedicated AIDS prevention workers come to support state-sponsored shortage of clean syringes in Vancouver, Canada

International Journal of Drug Policy

Volumn 15, Issue 1, 2004, Pages 36-45

  Spittal, P M ^a,b   Small, W ^c   Wood, E ^a,b   Johnston, C ^c   Charette, J ^c   Laliberte N ^c   O'Shaughnessy, M V ^a,b   Schechter, M T ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Vancouver Injection Drug Use Study   (Canada)

Author keywords

HIV; Single room occupancy; Syringes

Indexed keywords

ILLICIT DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANADA; DRUG ABUSE; DRUG USE; EPIDEMIC; ETHNOLOGY; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INJECTION; INSTRUMENT STERILIZATION; POLICY; PRIORITY JOURNAL; SYRINGE;

EID: 1642573167     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(03)00132-4     Document Type: Article

References (33)

1. Bardsley J., Turvey J., Blatherwick J. Vancouver's needle exchange program. Canadian Journal of Public Health. 81:1990;39-45.
2. Bellm J. Needle-exchange programmes are not the answer [letter; comment]. Lancet. 353:1999;1657-1661.
3. Bennett S.S. Needle-exchange programmes in the USA [letter comment] [see comments]. Lancet. 351:1998;839.
4. Blankenship K.M., Bray S.J., Merson M.H. Structural interventions in public health. AIDS. 14(Suppl. 1):2000;S11-S21.
5. Bluthenthal, R. N., Anderson, R., Flynn, N. M., Clancy, L., Anderson, K., & Kral, A. H. (2002). The role of harm reduction in syringe exchange programs (SEPs): Can it be measured and does it matter. In Proceedings of the fourth national harm reduction conference. Seattle WA, December 1-4.
6. Bluthenthal R.N., Kral A.H., Erringer E.A., Edlin B.R. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 18:1998;505-511.
7. Bourgois P. Anthropology and epidemiology on drugs: The challenges of cross-methodological and theoretical dialogue. International Journal of Drug Policy. 13:2002;259-269.
8. Bourgois P., Bruneau J. Needle exchange and the politics of science. Confronting Canada's cocaine injection epidemic with participant observation. Medical Anthropology. 18:2000;325-350.
9. Coffin P.O., Linas B.P., Factor S.H., Vlahov D. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. Journal of Urban Health. 77:2000;781-793.
10. Doherty M.C., Junge B., Rathouz P., Garfein R.S., Riley E., Vlahov D. The effect of a needle exchange program on numbers of discarded needles: A 2-year follow-up. American Journal of Public Health. 90:2000;936-939.
11. Fuller C.M., Ahern J., Vadnai L., Coffin P.O., Galea S., Factor S.H., Vlahov D. Impact of increased syringe access: Preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Journal of American Pharmaceutical Association (Washington). 42:2002;S77-S82.
12. Health Canada. (1998). Consortium to characterize injection drug users in Canada. Montreal, Canada.
13. Heimer R., Clair S., Teng W., Grau L.E., Khoshnood K., Singer M. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001. Journal of Urban Health. 79:2002;556-570.
14. Heimer R., Khoshnood K., Bigg D., Guydish J., Junge B. Syringe use and reuse: Effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 18(Suppl. 1):1998;S37-S44.
15. Lurie P., Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet. 349:1997;604-608.
16. Miller C.L., Johnston C., Spittal P.M., Li K., Laliberte N., Montaner J.S., Schechter M.T. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 36:2002a;737-742.
17. Miller C.L., Tyndall M., Spittal P., Li K., Palepu A., Schechter M.T. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. Journal of Urban Health. 79:2002b;257-265.
18. Moss A.R. Epidemiology and the politics of needle exchange [see comments]. American Journal of Public Health. 90:2000a;1385-1387.
19. Moss A.R. "For God's sake, don't show this letter to the president..." [comment]. American Journal of Public Health. 90:2000b;1395-1396.
20. Patrick D.M., Strathdee S.A., Archibald C.P., Ofner M., Craib K.J., Cornelisse P.G., Schechter M.T., Rekart M.L., O'Shaughnessy M.V. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS. 8:1997;437-445.
21. Rhodes T. The 'risk environment': A framework for understanding and reducing drug-related harm. International Journal of Drug Policy. 13:2002;84-94.
22. Schechter M.T., Strathdee S.A., Cornelisse P.G., Currie S., Patrick D.M., Rekart M.L., O'Shaughnessy M.V. Do needle exchange programmes increase the spread of HIV among injection drug users? An investigation of the Vancouver outbreak. AIDS. 13:1999;F45-F51.
23. Schensul, J., Compte, M. L., Hess, G., Nastasi, B., Berg, M., & Glasser, R. (1999). Using ethnographic data: Interventions, public programming and public policy. Ethnographers Toolkit.
24. Singer M., Stopka T., Siano C., Springer K., Barton G., Khoshnood K., Gorry de Puga A., Heimer R. The social geography of AIDS and hepatitis risk: Qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. American Journal of Public Health. 90:2000;1049-1056.
25. Spittal P.M., Craib K.J., Wood E., Laliberte N., Li K., Tyndall M.W., O'Shaughnessy M.V., Schechter M.T. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Canadian Medical Association Journal. 166:2002;894-899.
26. Strathdee S.A., Patrick D.M., Currie S.L., Cornelisse P.G., Rekart M.L., Montaner J.S., Schechter M.T., O'Shaughnessy M.V. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS. 11:1997;F59-F65.
27. Tyndall, M. W., Spittal, P., Wood, E., Li, K., O'Shaughnessy, M. V., & Schechter, M. T. (2003). Intensive injection cocaine as a primary risk factor for HIV in the Vancouver epidemic. AIDS.
28. Valente T.W., Foreman R.K., Junge B., Vlahov D. Satellite exchange in the Baltimore needle exchange program. Public Health Reports. 113:1998;90-96.
29. Wood E., Kerr T., Spittal P. An external evaluation of a peer run "unsanctioned" needle exchange program. Journal of Urban health. 80:2003;455-464.
30. Wood E., Schechter M.T., Tyndall M.W., Montaner J.S., O'Shaughnessy M.V., Hogg R.S. Antiretroviral medication use among injection drug users: Two potential futures [In Process Citation]. AIDS. 14:2000;1229-1235.
31. Wood E., Tyndall M W., Kerr T. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injection rooms help? Canadian Medical Association Journal. 165(4):2001;405-410.
32. Wood E., Tyndall M.W., Spittal P.M., Li K., Hogg R.S., Montaner J.S., O'Shaughnessy M.V., Schechter M.T. Needle exchange and difficulty with access during an ongoing HIV epidemic. International Journal of Drug Policy. 13:2002a;95-102.
33. Wood E., Tyndall M.W., Spittal P.M., Li K., Hogg R.S., Montaner J.S., O'Shaughnessy M.V., Schechter M.T. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 16:2002b;941-943.